Harmony Biosciences
Price & Volume
Stats
See more52W Range | $25.52-$40.87 |
Market Cap | $1.6B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $868.4M |
Revenue Growth (YoY) | 21.1% |
Gross Profit (12 Mos) | $670.1M |
Diluted EPS | $3.17 |
News
See moreYahoo Finance • 2 days ago
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Yahoo Finance • 5 days ago
Harmony Biosciences tumbles following Deutsche Bank, Truist downgrades
Yahoo Finance • 3 months ago
Harmony Biosciences To Present New Data From Phase 3 Trial Of EPX-100 In Dravet Syndrome Next Week
Yahoo Finance • 5 months ago
Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study
About
CEO | Dr. Jeffrey M. Dayno M.D. |
Address | 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 268 |
